AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26016699
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg/daily for 1 week and then for the first 2 days of every month for the following 3 months
Trial: 16393306
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 mg administered i.v. over 20 min
Trial: 15233978
Drug: Amlodipine/benazepril combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/benazepril combination therapy (5 mg and 10 mg with 40 mg benazepril)
Trial: 15233978
Drug: Benazepril hydrochloride
RxNorm normalized name: Benazepril Hydrochloride
DrugBank: Benazepril (DB00542)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benazepril hydrochloride (40 mg) alone
Trial: 11316720
Drug: Oral famciclovir
RxNorm normalized name: Famciclovir
DrugBank: Famciclovir (DB00426)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral famciclovir 500 mg three times daily
Trial: 11316720
Drug: Oral aciclovir
RxNorm normalized name: acyclovir Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aciclovir 800 mg five times daily
Trial: 3555587
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg + hydrochlorothiazide (HCTZ) 25 mg once daily
Trial: 18058818
Drug: Meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 7.5 mg/day for 10-14 days before surgery
Trial: 15319157
Drug: diclofenac‐Na 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac‐Na 0.1% Emulgel gel
Trial: 15319157
Drug: vehicle Emulgel
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vehicle Emulgel gel
Trial: 11149011
Drug: Weekly i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly i.v. bolus injection of 5‐fluorouracil 400 mg/m2 plus leucovorin 20 mg/m2
Trial: 11149011
Drug: Monthly i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly i.v. bolus injection of 5‐fluorouracil 425 mg/m2 plus leucovorin 20 mg/m2 for 5 consecutive days every 4 or 5 weeks
Trial: 11149011
Drug: Monthly arm
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly arm
Trial: 9076817
Drug: Miconazole gel
RxNorm normalized name: Miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole gel (25 mg, four times daily)
Trial: 3948857
Drug: WIEXP (water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WIEXP (water immersion with blood volume expansion by intravenous infusion of 2.0 L of isotonic saline for 2 hours)
Trial: 3948857
Drug: WIHEM (water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WIHEM (water immersion with blood volume reduction by loss of 0.5 L of blood during 30 minutes)
Trial: 25265927
Drug: DECT mode,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DECT mode, 0.5 ml per kg of patient weight CM at injection rate=(weight × 0.5 ml/kg)/(4+scan time)
Trial: 25265927
Drug: Single‐energy CT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single‐energy CT 70 ml CM at injection rate of 5 ml/s
Trial: 21900307
Drug: Questionnaire using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Questionnaire using the term 'nonspecific methods of treatment'
Trial: 17288679
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg plus hydrochlorothiazide 12.5 mg
Trial: 17288679
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg plus hydrochlorothiazide 12.5 mg
Trial: 16053996
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (low-dose angiotensin receptor blocker) for 2 years
Trial: 8674397
Drug: Cisapride (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (20 mg four times a day)
Trial: 3881327
Drug: Chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chenodeoxycholic acid 375 mg daily
Trial: 29744900
Drug: Fluconazole (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (loading dose 25 mg kg‐1; maintenance dose 12 mg kg‐1 day‐1 for infants <30 weeks or 20 mg kg‐1 day‐1 for infants ≥30 weeks' corrected gestational age)
Trial: 29744900
Drug: Micafungin (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin (loading dose 15 mg kg‐1 day‐1; maintenance dose 10 mg kg‐1 day‐1)
Trial: 23130467
Drug: Split drug
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Split drug regimen (two times a day)
Trial: 23130467
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily regimen
Trial: 16278523
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (verapamil/trandolapril or atenolol/hydrochlorothiazide)
Trial: 16278523
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (verapamil/trandolapril/hydrochlorothiazide or atenolol/hydrochlorothiazide/trandolapril)
Trial: 16278523
Drug: Monotherapy (verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (verapamil or atenolol)
Trial: 8560999
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg estradiol valerate
Trial: 8560999
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg norethisterone acetate
Trial: 18581513
Drug: Dichloroacetate (DCA)
RxNorm normalized name: dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (DCA) 40 mg/kg intravenously
Trial: 8806289
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further local treatment
Trial: 6427416
Drug: FAM combination
RxNorm normalized name: fam-trastuzumab deruxtecan-nxki Injection [Enhertu]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FAM combination (5‐fluorouracil, doxorubicin, and mitomycin C) - simultaneous administration
Trial: 6427416
Drug: FAM combination
RxNorm normalized name: fam-trastuzumab deruxtecan-nxki Injection [Enhertu]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FAM combination (5‐fluorouracil, doxorubicin, and mitomycin C) - sequential administration
Trial: 30827300
Drug: Oral massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral massage method with non-nutritive sucking, stimulating swallowing function, and SandraFucile, once a day for 14 consecutive days.
Trial: 30827300
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment of preterm infants without oral intervention.
Trial: 24365208
Drug: Intramuscular ergometrine
RxNorm normalized name: Ergometrine
DrugBank: Ergometrine (DB01253)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ergometrine (0.5mg)
Trial: 18639450
Drug: Irinotecan (IRI),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan (IRI), Leucovorin (LV), and bolus 5-fluorouracil (5FU) administered weekly (80 mg/m2 IV IRI, 200 mg/m2 LV, 450 mg/m2 bolus 5FU) for six cycles followed by pelvic irradiation plus 5FU.
Trial: 18639450
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: Leucovorin (LV) and bolus 5-fluorouracil (5FU) (200 mg/m2 LV and 450 mg/m2 IV bolus 5FU) for six cycles followed by pelvic irradiation plus 5FU.
Trial: 15947501
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acetyl‐L‐carnitine, n‐3 fatty acids, and coenzyme Q10 (Phototrop)
Trial: 12757966
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg sublingual buprenorphine tablets administered four times a day
Trial: 1707646
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of enalapril and sulindac
Trial: 30420616
Drug: 3 months
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 months (3M) adjuvant chemotherapy
Trial: 30420616
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months (6M) adjuvant chemotherapy
Trial: 27465309
Drug: Contamination-focused exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contamination-focused exposure therapy (3 sessions of 30 minutes each)
Trial: 27465309
Drug: Contamination-focused exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contamination-focused exposure therapy
Trial: 24273218
Drug: Whole soy
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole soy (40 g soy flour)
Trial: 24273218
Drug: Purified daidzein
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified daidzein (63 mg)
Trial: 20635286
Drug: REMAS intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: REMAS intervention in psychosocial outpatient treatment
Trial: 16521631
Drug: Parnaparin 6400
RxNorm normalized name: parnaparin
DrugBank: Parnaparin (DB09260)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parnaparin 6400 IU subcutaneously once daily for 7 days
Trial: 16521631
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (IV bolus of 5000 IU followed by infusion of 800 to 1000 IU/hour for 48 hours, then 5000 IU subcutaneously every 6 hours for 5 days)
Trial: 8681660
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (800 micrograms beclomethasone dipropionate)
Trial: 1992412
Drug: Amoxicillin, 500
RxNorm normalized name: Amoxicillin, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin, 500 mg three times daily for 14 days
Trial: 19100012
Drug: Tongxinluo therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongxinluo therapy
Trial: 9356558
Drug: Personal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personal therapy
Trial: 3542088
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of dry cold air (causing significant bronchoconstriction)
Trial: 3542088
Drug: Methacholine test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine test without prior cold air inhalation
Trial: 29848147
Drug: Seltorexant 40
RxNorm normalized name: Seltorexant
DrugBank: Seltorexant (DB14961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seltorexant 40 mg for five days
Trial: 20308694
Drug: Comprehensive multinutrient
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive multinutrient supplement (SUPP)
Trial: 15739035
Drug: Alendronate (Aln,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (Aln, 10 mg/day) plus Raloxifene (Rlx, 60 mg/day)
Trial: 15739035
Drug: Alendronate (Aln,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (Aln, 10 mg/day) plus Hormone Replacement Therapy (HRT, 0.625 mg/day conjugated equine estrogens plus 2.5 mg/day medroxyprogesterone acetate)
Trial: 15739035
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) alone
Trial: 11994888
Drug: Risperidone 0.5-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 0.5-2 mg/day
Trial: 11994888
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of rivastigmine and risperidone
Trial: 10349921
Drug: Vecuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium administered with sevoflurane 2% (group 2)
Trial: 10349921
Drug: Vecuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium administered with sevoflurane 2% after 30 min (group 3)
Trial: 10349921
Drug: Vecuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium administered with sevoflurane 2% after 60 min (group 4)
Trial: 8602306
Drug: Depot goserelin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depot goserelin, 3.6 mg subcutaneous implant given monthly
Trial: 8602306
Drug: Danazol, 200
RxNorm normalized name: Danazol, 200 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol, 200 mg two times per day
Trial: 1760910
Drug: Senna tablets
DrugBank: Senna leaf (DB15889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna tablets
Trial: 1760910
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no bowel preparation)
Trial: 1760910
Drug: Senna tablets
DrugBank: Senna leaf (DB15889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna tablets and Sodium picosulphate powder
Trial: 1760910
Drug: Laxatives (general)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laxatives (general)
Trial: 6109500
Drug: Almitrine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine (1.5 mg/kg over a period of one hour)
Trial: 31087640
Drug: Chemotherapy and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and/or tumour bed boost radiotherapy (TBBR)
Trial: 28748002
Drug: High serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High serum folate concentrations (>45.3 nmol/L)
Trial: 24228854
Drug: Monday to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monday to Saturday rehabilitation (additional Saturday rehabilitation comprising physiotherapy and occupational therapy)
Trial: 10792560
Drug: HRT (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (2 mg oestradiol valerate for the first 3 months with the addition of 10 mg medroxyprogesterone for 10 days every third month thereafter)
Trial: 30095022
Drug: Vitamin D2
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin D2 supplement 40,000 IU/week
Trial: 22410658
Drug: Topical 0.25%
RxNorm normalized name: permethrin topical 0.25% topical kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.25% timolol maleate gel
Trial: 19156926
Drug: Temozolomide (TMZ)
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide (TMZ) treatment
Trial: 17227902
Drug: Topotecan 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan 1.5 mg/m2 for 5 days every 21 days
Trial: 15753495
Drug: Landiolol (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (0.3 mg.kg(‐1))
Trial: 15753495
Drug: Landiolol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (0.1 mg.kg(‐1))
Trial: 15753495
Drug: Landiolol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (0.1 and 0.3 mg.kg(‐1))
Trial: 11948832
Drug: NC100150 (between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NC100150 (between 0.75 and 6 mg of Fe/kg of body weight)
Trial: 11948832
Drug: High-dose NC100150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose NC100150
Trial: 9465799
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (400 micrograms intravenously every 8 hours four times)
Trial: 2165899
Drug: Fluocortolone (15-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocortolone (15-30 mg)
Trial: 366721
Drug: Benoxaprofen (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benoxaprofen (300 mg on the first day followed by 100 mg twice daily)
Trial: 16366740
Drug: Herbal supplement
RxNorm normalized name: LYDIA PINKHAM Herbal Supplement Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal supplement containing 600 mg black tea extract (60% polyphenols, 20% caffeine) and 442 mg guarana extract (36% caffeine)
Trial: 11297904
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg CQ
Trial: 11297904
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg CQ
Trial: 3283227
Drug: Betaxolol, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol, 20 mg/day
Trial: 3283227
Drug: Verapamil, 240‐480
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil, 240‐480 mg/day
Trial: 27719677
Drug: Community health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community health workers' knowledge and practice regarding pre-eclampsia identification and treatment
Trial: 23277147
Drug: Intragastric nitrate
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric nitrate administration in BPSDL rats
Trial: 17522618
Drug: L-5-methyltetrahydrofolate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-5-methyltetrahydrofolate (1 mg)
Trial: 11123867
Drug: Primary systemic
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary systemic chemotherapy
Trial: 8833458
Drug: 0.02% cinnamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02% cinnamic aldehyde in ethanol (patch test)
Trial: 8833458
Drug: Patch test
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch test sensitivity
Trial: 6740101
Drug: Oral trivalent
RxNorm normalized name: poliomyelitis oral, trivalent, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trivalent poliovirus vaccine (OPV)
Trial: 6740101
Drug: Injectable trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable trivalent poliovirus vaccine (IPV)
Trial: 19844113
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 0.066 mg/kg/day
Trial: 10695417
Drug: Cisapride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (10 mg TID for 2 weeks)
Trial: 8942586
Drug: Oral transmucosal
RxNorm normalized name: Thrive, 2 mg oral transmucosal gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral transmucosal fentanyl citrate (OTFC) at a dose of 15 micrograms/kg
Trial: 8942586
Drug: Placebo lozenge/IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lozenge/IV fentanyl
Trial: 6377878
Drug: Intravenous cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cimetidine plus a blinded nasogastric tube
Trial: 6377878
Drug: Intravenous cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cimetidine plus nasogastric suction
Trial: 30185428
Drug: Multisystemic Therapy‐Health
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic Therapy‐Health Care (6-month home‐ and community‐based treatment)
Trial: 30185428
Drug: Attention control
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Attention control group (weekly family supportive counseling for 6 months)
Trial: 23117724
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment (aspirin 100mg plus clopidogrel 75 mg/d)
Trial: 18370571
Drug: Omega-3 PUFAs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 PUFAs (3.4 g/d)
Trial: 15728439
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba (120 mg, one capsule/day for 6 weeks)
Trial: 15728439
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching capsule for 6 weeks)
Trial: 12971422
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols (2.3 g per day)
Trial: 10550273
Drug: roxithromycin 150
RxNorm normalized name: roxithromycin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin 150 mg twice daily for a mean of 26 days (range 17-35 days)
Trial: 1794921
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of new medication
Trial: 1794921
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of new medication
Trial: 6135635
Drug: Somatostatin infusion
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin infusion at a constant rate of 250 μg/h from 22.00 h until 07.00 h